Objective: To explore the application value of bifidobacterium and montmorillonite powder in the treatment of pediatric diarrhea. Methods:From June 2017 to February 2018, 84 children with diarrhea were selected. According to the difference of treatment style, it was divided into observation group (n=42) and control group (n=42). Montmorillonite powder was used in the control group and living bifidobacterium bacteria in the observation group. The value of two treatment methods was compared. Results: Compared with the control group, the clinical efficacy and the time of disappearance of clinical signs in the observation group were significantly improved (P0.05). Conclusion: The combination of Bifidobacterium and Montmorillonite powder instead of single use Montmorillonite powder should be used in the treatment of infantile diarrhea. It is of great significance to shorten the time of disappearance of clinical signs and promote the improvement of clinical efficacy. At the same time, it will not increase the risk of drug use in children. Therefore, the clinical value is significant.%目的:探讨小儿腹泻治疗中双歧杆菌活菌与蒙脱石散联合的应用价值.方法:择选2017年6月—2018年2月,我院收治的腹泻患儿84例作为研究主体.以治疗方式差异作为分组依据,划分为观察组(n=42)和对照组(n=42).将蒙脱石散应用于对照组,观察组则以对照组为基础和前提,加用双歧杆菌活菌.对两种治疗方式的价值对比分析.结果:观察组患儿在临床疗效、临床体征消失时间上与对照组比对,改善效果均显著(P0.05).结论:双歧杆菌活菌与蒙脱石散联合代替单一使用蒙脱石散应用于小儿腹泻治疗中,对于缩短临床体征消失时间,促进其临床疗效的提升,意义非凡.同时,还不会增加患儿用药风险性,因此,临床应用价值显著.
展开▼
